Oxecone-M 400 mg Chewable Tablet Uses, Dosage, Side Effects and more
Oxecone-M 400 mg Chewable Tablet is a hydroxymagnesium aluminate complex that is converted rapidly in gastric acid to Mg(OH)2 and Al(OH)3, which are absorbed poorly and thus provide a sustained antacid effect
Attribute | Details |
---|---|
Trade Name | Oxecone-M 400 mg Chewable Tablet |
Availability | Discontinued |
Generic | Magaldrate |
Magaldrate Other Names | Aluminium magnesium hydroxide sulfate hydrate, Aluminum magnesium hydroxide sulfate hydrate, Aluminum magnesium hydroxide sulphate hydrate, Hydrate magnesium aluminate activated sulfate, Magaldrate, Magaldrato, Magaldratum, Magnesium aluminate hydrate, Monalium hydrate |
Related Drugs | omeprazole, famotidine, Pepcid, Prilosec, ranitidine, calcium carbonate |
Weight | 400 mg |
Type | Chewable Tablet |
Formula | Al5H33Mg10O40S2 |
Weight | Average: 1115.3 Monoisotopic: 1111.7570627 |
Groups | Approved, Withdrawn |
Therapeutic Class | Antacids, Anti-dyspeptic/Carminatives |
Manufacturer | ACME Laboratories Ltd. |
Available Country | Bangladesh |
Last Updated: | January 7, 2025 at 1:49 am |
Uses
Oxecone-M 400 mg Chewable Tablet is used to relieve symptoms of dyspepsia, heartburn, acid indigestion, sour stomach, gastroesophageal reflux, hiatal hernia and flatulence. It is also prescribed in hyperacidity associated with peptic ulcers, gastritis and esophagitis. Oxecone-M 400 mg Chewable Tablet may be given to children if necessary.
Oxecone-M 400 mg Chewable Tablet is also used to associated treatment for these conditions: Acid indigestion, Aspiration, Bloating, Calcinosis, Dyspepsia, Gastroesophageal Reflux, Gastrointestinal Bleeding, Heartburn, Hyperacidity, Hyperparathyroidism, Kidney Stones, Peptic Ulcer, Stress Ulcers
Dosage
Tablet: 1-3 tablets, after meals and at bed time or as directed by the physician.
Syrup: 2 to 3 teaspoonful, 3 or 4 times daily, half to one hour after or before meal and at bedtime
Side Effects
Constipation and diarrhea may occur.
See simplified version Oxecone-M 400 mg Chewable Tablet also Oxecone-M 400 mg Chewable Tablet in banglaFood Interaction
- Avoid alcohol.
Drug Interaction
Moderate: rosuvastatinUnknown: amoxicillin / clavulanate, glucose, hydrochlorothiazide, pilocarpine ophthalmic, escitalopram, amlodipine, acetaminophen, tiotropium, diltiazem
Disease Interaction
Major: constipation, renal dysfunctionModerate: diarrhea
Elimination Route
Aluminium oxide: absorbed Al ions are eliminated in the urine (0.1-0.5 mg of Al in aluminium-containing antacid is absorbed from standard daily doses of antacid) while insoluble or poorly absorbed Al salts in the intestines are excreted through the feces.
Magnesium oxide: absorbed Mg ions (up to 30%) are eliminated in the urine, unabsorbed is excreted in the feces.
Pregnancy & Breastfeeding use
Pregnant women: Oxecone-M 400 mg Chewable Tablet may be used in pregnancy if indicated however one should avoid excessive dosage.
Lactating mother: Oxecone-M 400 mg Chewable Tablet may pass into breast milk but has not been reported to cause problem in nursing babies.
Contraindication
Oxecone-M 400 mg Chewable Tablet is contraindicated in patients with known hypersensitivity to magnesium and aluminium. It is also contraindicated in patients with impaired renal function